Sung-gil Q. Chi

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 80 publications

Musashi-1 Drives Radioresistance and Stemness in Head and Neck Squamous Cell Carcinoma via a Radioresistant FaDu Model.

Musashi-1 Drives Radioresistance and Stemness in Head and Neck Squamous Cell Carcinoma via a Radioresistant FaDu Model.

Journal: Cancer science

Published: May 06, 2026

Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast Cancer.

Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast Cancer.

Journal: Small (Weinheim an der Bergstrasse, Germany)

Published: May 02, 2025

Propionate suppresses colitis-associated colorectal cancer in mice by Or51e2.

Propionate suppresses colitis-associated colorectal cancer in mice by Or51e2.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: April 17, 2025

RASSF4 Suppresses Gastric Tumor Growth through Activation of Chk2-p53 Signaling Axis.

RASSF4 Suppresses Gastric Tumor Growth through Activation of Chk2-p53 Signaling Axis.

Journal: Cancer research and treatment

Published: February 05, 2025

XAF1 antagonizes TRIM28 activity through the assembly of a ZNF313-mediated destruction complex to suppress tumor malignancy.

XAF1 antagonizes TRIM28 activity through the assembly of a ZNF313-mediated destruction complex to suppress tumor malignancy.

Journal: Molecular biomedicine

Published: July 23, 2024

XAF1 is secreted from stressed tumor cells to activate T cell-mediated tumor surveillance via Lck-ERK signaling.

XAF1 is secreted from stressed tumor cells to activate T cell-mediated tumor surveillance via Lck-ERK signaling.

Journal: Neoplasia (New York, N.Y.)

Published: July 16, 2024

β-Ionone suppresses colorectal tumorigenesis by activating OR51E2, a potential tumor suppressor.

β-Ionone suppresses colorectal tumorigenesis by activating OR51E2, a potential tumor suppressor.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: July 14, 2024

Targeting miR-21 to Overcome P-glycoprotein Drug Efflux in Doxorubicin-Resistant 4T1 Breast Cancer.

Targeting miR-21 to Overcome P-glycoprotein Drug Efflux in Doxorubicin-Resistant 4T1 Breast Cancer.

Journal: Biomaterials research

Published: July 01, 2024

Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death.

Targeted delivery of anti-miRNA21 sensitizes PD-L1high tumor to immunotherapy by promoting immunogenic cell death.

Journal: Theranostics

Published: April 25, 2024

Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma.

Polyamine and EIF5A hypusination downstream of c-Myc confers targeted therapy resistance in BRAF mutant melanoma.

Journal: Molecular cancer

Published: January 02, 2024

Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy.

Design of PD-L1-Targeted Lipid Nanoparticles to Turn on PTEN for Efficient Cancer Therapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: December 18, 2023

Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters.

Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters.

Journal: Biomedicines

Published: September 05, 2023

Showing 1-12 of 80

Last Updated: 09/26/2026